Product Details

Co Meloxicam

Meloxicam
7.5 mg
Tablet


DIN/PIN/NPN

02250012

Manufacturer

Cobalt Pharmaceuticals Company

Formulary Listing Date

2004-09-14  

Unit Price

0.2003

Amount MOH Pays

0.2003

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Meloxicam 7.5 mg Tablet: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.

ATC Code

M01AC06

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02258315 Teva-Meloxicam 0.2003 0.2003
02248267 PMS-Meloxicam 0.2003 0.2003
02242785 Mobicox NA NA
02250012 Co Meloxicam 0.2003 0.2003
02390884 Auro-Meloxicam 0.2003 0.2003
02248973 Apo-Meloxicam 0.2003 0.2003
02353148 Meloxicam 0.2003 0.2003
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph